Name: Cytokine-Based Immunotherapy - Part a (Volume 396) (International Review of Cell and Molecular Biology, Volume 396) (en Inglés)
Price: 274790.00 CLP
Availability: InStock
Author: Berraondo Pedro,Galluzzi Lorenzo,Aranda Vega Fernando
ISBN: 9780443297267

portada Cytokine-Based Immunotherapy - Part a (Volume 396) (International Review of Cell and Molecular Biology, Volume 396) (en Inglés)

Cytokine-Based Immunotherapy - Part a (Volume 396) (International Review of Cell and Molecular Biology, Volume 396) (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Berraondo Pedro,Galluzzi Lorenzo,Aranda Vega Fernando

Idioma

Inglés

N° páginas

212

Encuadernación

Tapa Dura

ISBN13

9780443297267

Cytokine-Based Immunotherapy - Part a (Volume 396) (International Review of Cell and Molecular Biology, Volume 396) (en Inglés)

Berraondo Pedro,Galluzzi Lorenzo,Aranda Vega Fernando (Autor) · Academic Press · Tapa Dura

Libro Nuevo Importado

Envío: 18 a 23 días háb.

$ 457.980$ 274.790

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 274.790

Llega entre el 02 Sep y el 09 Sep a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Cytokine-Based Immunotherapy - Part a (Volume 396) (International Review of Cell and Molecular Biology, Volume 396) (en Inglés)"

Cytokine-Based immunotherapy, Volume 396, Part A delves into the intricate world of cytokines, vital signaling proteins that orchestrate the immune response and their pivotal role in modulating various immune functions. From their fundamental mechanisms to their therapeutic applications, this book offers a thorough examination of the latest trends and developments in leveraging cytokines for immunotherapy. The book includes chapters such as Cytokine-driven cancer immune evasion mechanisms, which explores how cytokines contribute to cancer cells' ability to evade the immune system. Cytokine-based immunotherapy in hematolymphoid malignancies is also explored, discussing the use of cytokines in treating blood cancers. Targeting TNF-alpha examines the immunotherapeutic approach for alleviating neuropathic pain. The key role of immunomodulatory cytokines for the development of novel nk cell-based cancer therapies focuses on the importance of cytokines in developing new cancer treatments. Finally, complexities in the clinical development of TGFβ inhibitors covers the challenges in creating inhibitors for TGFβ.